Sandra Bibbo

Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Chronic low-dose of BPS and PFOS alter adipogenic programming and impair insulin responsiveness in human adipocytes.

Chronic low-dose of BPS and PFOS alter adipogenic programming and impair insulin responsiveness in human adipocytes.

Journal: Journal of endocrinological investigation

Published: February 04, 2026

Endocrine-disrupting effects of environmental BPS and PFOS on human brain organoid development.

Endocrine-disrupting effects of environmental BPS and PFOS on human brain organoid development.

Journal: Frontiers in endocrinology

Published: August 25, 2025

Interference of estrogen signaling by endocrine disruptors in male and female cells: Potential implications of BPS and PFOS in human development.

Interference of estrogen signaling by endocrine disruptors in male and female cells: Potential implications of BPS and PFOS in human development.

Journal: European journal of cell biology

Published: January 30, 2025

A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy.

A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy.

Journal: International journal of biological macromolecules

Published: January 09, 2025

Exploring Potential Impact of Graphene Oxide and Graphene Oxide-Polyethylenimine on Biological Behavior of Human Amniotic Fluid-Derived Stem Cells.

Exploring Potential Impact of Graphene Oxide and Graphene Oxide-Polyethylenimine on Biological Behavior of Human Amniotic Fluid-Derived Stem Cells.

Journal: International journal of molecular sciences

Published: October 28, 2024

Unraveling the Epigenetic Landscape: Insights into Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis.

Unraveling the Epigenetic Landscape: Insights into Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis.

Journal: Brain sciences

Published: April 10, 2024

EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.

EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 03, 2023

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers.

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers.

Journal: Heliyon

Published: September 22, 2023

Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.

Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.

Journal: International journal of molecular sciences

Published: November 07, 2022

MYC regulates metabolism through vesicular transfer of glycolytic kinases.

MYC regulates metabolism through vesicular transfer of glycolytic kinases.

Journal: Open biology

Published: December 01, 2021

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in asymptomatic vaccinated healthcare workers.

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in asymptomatic vaccinated healthcare workers.

Journal: Infection control and hospital epidemiology

Published: May 10, 2021

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.

Journal: Cancers

Published: August 29, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026